Search

everythinglearnresearchcommunity

for

Search:↓

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Finasteride helps induce ovulation in nonresponder PCOS women.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

PCOS may be influenced by factors in the blood, not just the ovaries.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

PCOS may have evolved as an advantage in past environments with food scarcity.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.